CLINICIP

Hyperglycaemia and insulin resistance are common in critically ill patients, even when glucose homeostasis has previously been normal. Recent medical studies brought evidence that treatment of high glucose levels with insulin will dramatically improve survival chances in these patients. However, treatment of glycaemia with target glucose levels close to physiological range is labour-intensive and although the cause/effect is well-known, the unmanageable workload and the prevalent fear of hypoglycaemiae among critical care physicians still prevent the general implementation of glycaemic control in the intensive care unit.

Therefore, the overall goal of CLINICIP is to establish glycaemic control on an automated basis in order to improve survival chances in intensive care units.

For further information, please visit:
http://www.clinicip.org

Project co-ordinator:
JOANNEUM RESEARCH Forschungsgesellschaft mbH

Partners:

• JOANNEUM RESEARCH Forschungsgesellschaft mbH (AT)
• Disetronic Medical Systems AG (CH)
• Medizinische Universität Graz (AT)
• Technische Universität Graz (AT)
• Univerzita Karlova V Praze (CZ)
• Royal Brompton and Harefield NHS Trust (UK)
• Consiglio Nazionale delle Ricerche (IT)
• SensLab Gesellschaft zur Entwicklung und Herstellung bioelektrochemischer Sensoren mbH (DE)
• Gesellschaft zur Förderung der Analytischen Wissenschaften e.V. (DE)
• GAMBRO Dialysatoren GmbH (DE)
• Katholieke Universiteit Leuven (BE)
• The Chancellor, Masters and Scholars of the University of Cambridge (UK)
• B.Braun Melsungen AG (DE)

Timetable: 01/04 – to 12/07

Total cost: € 11.256.588

EC funding: € 7.500.000

Instrument: IP

Project Identifier: IST-2002-506965

Source: FP6 eHealth Portfolio of Projects